Quality Control 40-80% (hourly based)
Publication date:
28 March 2025Workload:
40 – 80%Contract type:
Unlimited employment- Place of work:Fehraltorf (Zurich), Switzerland
Job summary
Celerion, a leading bioanalytical CRO, has supported pharma and biotech for 40+ years. Join us for a chance to work in a dynamic environment with flexible hours.
Tasks
- Assist the quality control team in reviewing GxP study documents.
- Verify the completeness and correctness of generated data.
- Review the accuracy of data tables for studies.
Skills
- Students in Pharmacology, Biology, or (Bio)Chemistry preferred.
- Good German and English communication skills.
- Reliable, precise, and highly motivated team player.
Is this helpful?
Celerion is a top-tier bioanalytical contract research organization that has been assisting pharmaceutical and biotech companies worldwide for over four decades. Celerion provides comprehensive services for new drug approval, ranging from early development to clinical trials, with the goal of expediting patient access to new treatments.
For the earliest possible entry date we are looking for a student in the field of
Quality Control 40-80% (hourly based)
\n
- Your tasks include assisting the quality control (QC) team to review GxP study documents (paper based and electronic data). Your responsibilities include checking the correctness of generated data, verifying the completeness of study data, and reviewing the accuracy of data tables.
- Students in the field of Pharmacology/Biology/(Bio)Chemistry preferred
- Good German and English skills
- Team player, reliable, precise, highly motivated, good self-organization
- Interesting work in an open, dynamic team
- "On the job" training in regulatory (GxP) bioanalysis
- Modern infrastructure
- Flexible working hours (Mon to Fri, no weekends, no shifts)
\n
Do you have any questions? Your contact person Iris Rüttimann (HR Manager) is happy to help you at 043 355 76 76.
Would this be your new challenge? Then we look forward to receiving your complete application documents.